These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37666821)

  • 1. Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39.
    Campagne S; Jutzi D; Malard F; Matoga M; Romane K; Feldmuller M; Colombo M; Ruepp MD; Allain FH
    Nat Commun; 2023 Sep; 14(1):5366. PubMed ID: 37666821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15.
    Ting TC; Goralski M; Klein K; Wang B; Kim J; Xie Y; Nijhawan D
    Cell Rep; 2019 Nov; 29(6):1499-1510.e6. PubMed ID: 31693891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-binding motif protein 39 (RBM39): An emerging cancer target.
    Xu Y; Nijhuis A; Keun HC
    Br J Pharmacol; 2022 Jun; 179(12):2795-2812. PubMed ID: 33238031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal Erythropoiesis.
    Huang SC; Zhang HS; Yu B; McMahon E; Nguyen DT; Yu FH; Ou AC; Ou JP; Benz EJ
    Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28193846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
    Bussiere DE; Xie L; Srinivas H; Shu W; Burke A; Be C; Zhao J; Godbole A; King D; Karki RG; Hornak V; Xu F; Cobb J; Carte N; Frank AO; Frommlet A; Graff P; Knapp M; Fazal A; Okram B; Jiang S; Michellys PY; Beckwith R; Voshol H; Wiesmann C; Solomon JM; Paulk J
    Nat Chem Biol; 2020 Jan; 16(1):15-23. PubMed ID: 31819272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820.
    Du X; Volkov OA; Czerwinski RM; Tan H; Huerta C; Morton ER; Rizzi JP; Wehn PM; Xu R; Nijhawan D; Wallace EM
    Structure; 2019 Nov; 27(11):1625-1633.e3. PubMed ID: 31693911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
    Han T; Goralski M; Gaskill N; Capota E; Kim J; Ting TC; Xie Y; Williams NS; Nijhawan D
    Science; 2017 Apr; 356(6336):. PubMed ID: 28302793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUF60-activated exons uncover altered 3' splice-site selection by germline missense mutations in a single RRM.
    Královicová J; Ševcíková I; Stejskalová E; Obuca M; Hiller M; Stanek D; Vorechovský I
    Nucleic Acids Res; 2018 Jul; 46(12):6166-6187. PubMed ID: 29788428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on the biological functions and diverse regulation of RNA-binding protein 39 and their implication in human diseases.
    Eléouët M; Lu C; Zhou Y; Yang P; Ma J; Xu G
    Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194902. PubMed ID: 36535628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global regulation of alternative RNA splicing by the SR-rich protein RBM39.
    Mai S; Qu X; Li P; Ma Q; Cao C; Liu X
    Biochim Biophys Acta; 2016 Aug; 1859(8):1014-24. PubMed ID: 27354116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-domain Flexibility of Human Ser/Arg-Rich Splicing Factor 1 Allows Variable Spacer Length in Cognate RNA's Bipartite Motifs.
    De Silva NIU; Fargason T; Zhang Z; Wang T; Zhang J
    Biochemistry; 2022 Dec; 61(24):2922-2932. PubMed ID: 36454680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.
    Zhang R; Wang W; Zhang N; Chen X; Liu W; Zhang L; Liu N
    J Cell Mol Med; 2022 Sep; 26(18):4859-4871. PubMed ID: 35989423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.
    Ji T; Yang Y; Yu J; Yin H; Chu X; Yang P; Xu L; Wang X; Hu S; Li Y; Wu X; Liu W; Zhou B; Wang W; Zhang S; Cheng W; Chen Y; Shi L; Li Z; Zhuo R; Zhang Y; Tao Y; Wu D; Li X; Zhang Z; Fan JJ; Pan J; Lu J
    J Exp Clin Cancer Res; 2024 Jul; 43(1):205. PubMed ID: 39044280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein 39: a promising therapeutic target for cancer.
    Xu C; Chen X; Zhang X; Zhao D; Dou Z; Xie X; Li H; Yang H; Li Q; Zhang H; Di C
    Cell Death Discov; 2021 Aug; 7(1):214. PubMed ID: 34389703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Genetic Screen for Pre-mRNA Splicing Mutants of
    Kanno T; Lin WD; Fu JL; Chang CL; Matzke AJM; Matzke M
    Genetics; 2017 Dec; 207(4):1347-1359. PubMed ID: 28971960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
    Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUBP1 is a general splicing factor facilitating 3' splice site recognition and splicing of long introns.
    Ebersberger S; Hipp C; Mulorz MM; Buchbender A; Hubrich D; Kang HS; Martínez-Lumbreras S; Kristofori P; Sutandy FXR; Llacsahuanga Allcca L; Schönfeld J; Bakisoglu C; Busch A; Hänel H; Tretow K; Welzel M; Di Liddo A; Möckel MM; Zarnack K; Ebersberger I; Legewie S; Luck K; Sattler M; König J
    Mol Cell; 2023 Aug; 83(15):2653-2672.e15. PubMed ID: 37506698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.
    Faust TB; Yoon H; Nowak RP; Donovan KA; Li Z; Cai Q; Eleuteri NA; Zhang T; Gray NS; Fischer ES
    Nat Chem Biol; 2020 Jan; 16(1):7-14. PubMed ID: 31686031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing Site Recognition by Synergy of Three Domains in Splicing Factor RBM10.
    Serrano P; Hammond JA; Geralt M; Wüthrich K
    Biochemistry; 2018 Mar; 57(10):1563-1567. PubMed ID: 29450990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA recognition by Npl3p reveals U2 snRNA-binding compatible with a chaperone role during splicing.
    Moursy A; Cléry A; Gerhardy S; Betz KM; Rao S; Mazur J; Campagne S; Beusch I; Duszczyk MM; Robinson MD; Panse VG; Allain FH
    Nat Commun; 2023 Nov; 14(1):7166. PubMed ID: 37935663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.